Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.75M Sell
6,546
-179
-3% -$48.5K 0.03% 942
2025
Q4
$1.69M Buy
+6,725
New +$1.79M 0.04% 677
2024
Q4
Sell
-2,420
Closed -$541K 2650
2024
Q3
$541K Sell
2,420
-3,862
-61% -$849K 0.04% 754
2024
Q2
$1.28M Buy
6,282
+722
+13% +$147K 0.11% 273
2024
Q1
$1.21M Buy
+5,560
New +$1.22M 0.16% 106
2023
Q4
Sell
-8,874
Closed -$1.78M 1871
2023
Q3
$1.78M Buy
8,874
+3,821
+76% +$806K 0.3% 17
2023
Q2
$1.05M Buy
+5,053
New +$980K 0.19% 75
2022
Q3
Sell
-1,390
Closed -$280K 1258
2022
Q2
$280K Buy
+1,390
New +$296K 0.11% 300

Other funds holding LH

XTX Topco's LH Position: Q1 2026 in Review

XTX Topco reduced its Labcorp (LH) stake by 2.7% in Q1 2026, selling an estimated $48.5K and leaving 6,546 shares worth $1.75M. The position accounts for 0.03% of the portfolio, ranked #942.

XTX Topco first reported a position in LH in Q2 2022 and has held it in 8 quarters since. The position peaked at $1.78M in Q3 2023. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • XTX Topco held 6,546 shares of Labcorp worth $1.75M as of Q1 2026.
  • XTX Topco sold 179 Labcorp shares in Q1 2026, an estimated $48.5K.
  • Labcorp made up 0.03% of XTX Topco's portfolio in Q1 2026, its #942 holding.
  • XTX Topco first reported a position in Labcorp in Q2 2022 and has held it in 8 quarters since.
  • XTX Topco's Labcorp position peaked at $1.78M in Q3 2023.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.